Our findings provide evidence for long-term involvement of risk assessment in such patients and suggest a likely application of NT-proBNP changes as novel predictor candidates of clinical outcomes and valuable indicators for risk stratification of patients with CHF complicated by CKD. Here, NPPB is linked to congestive heart failure.